Related Experiment Videos
[Serous retinal detachment. Value of acetazolamide]
Journal Francais D'Ophtalmologie
|January 1, 1992
Summary
Acetazolamide effectively treated serous retinal detachment in 38 patients, improving vision and reducing fluid buildup. This offers new hope for conditions often lacking treatment options.
Area of Science:
- Ophthalmology
- Pharmacology
Context:
- Serous retinal detachment (SRD) presents diverse etiologies.
- Established treatments for SRD are limited, necessitating novel therapeutic approaches.
Purpose:
- To evaluate the efficacy of acetazolamide in treating serous retinal detachment across various causes.
- To assess clinical and angiographic outcomes in patients with SRD treated with acetazolamide.
Summary:
- 38 patients with SRD (age-related macular degeneration, central serous chorioretinopathy, epiretinal membranes, etc.) received acetazolamide (0.375 g/day) for five weeks.
- Observed outcomes included reduced metamorphopsia, stable or improved visual acuity, and SRD resorption confirmed by fluorescein angiography.
- Clinical and angiographic findings supported acetazolamide's value in SRD treatment.
Impact:
- Acetazolamide demonstrates potential as a valuable treatment for serous retinal detachment.
- These findings offer hope for managing retinal diseases previously considered difficult to treat.